Cancer or blood disorder patients may have central lines, which make it easier to receive certain medications (such as chemotherapy) and have blood tests. The major types of central lines include Port-A-Cath, Hickman, and peripherally inserted central catheter (PICC). Patients receiving stem cell transplants sometimes have central lines. If you have a central line, you may need to care for it at home. Or you may need guidance in caring for a loved one with a central line. Knowing the correct procedures is essential to preventing infection.
by Martha Laperle When my son Ryan ran the Boston Marathon this year, I watched him with a special level of pride. Not only had he completed his first-ever marathon in four hours, but he was running, in large part, because of me. Just over a year earlier, at the age of 57, I had been diagnosed with an aggressive form of acute myeloid leukemia (AML), a diagnosis that turned my life upside down and led to weeks of chemotherapy and a stem cell transplant at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC). Ryan was running to raise funds for the …
September is Childhood Cancer Awareness Month. We asked Lisa Diller, MD, chief medical officer at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, to answer these important questions. What signs might lead a child’s pediatrician to suspect cancer? Cancer is very diverse, and diagnosis is further complicated because many signs and symptoms—like fever, bruising and headaches—are normal in healthy children.
Quite a few substances used in traditional medicine in China or other countries have received Food and Drug Administration (FDA) approval as cancer drugs… and their numbers are growing. Some examples are: Arsenic trioxide, made from arsenic sulfide ore, has been used therapeutically for more than 2,400 years. Following promising reports from China, the agent was tested in clinical trials and received FDA approval in 2000 for patients with acute promyelocytic leukemia who have not responded to other therapies or whose disease has recurred.
by Naomi Funkhouser April 2011 was an auspicious month for Hilary Hall. The start of spring marked 15 years of her being cancer-free, as well as the anniversary of her bone marrow transplant in April 1996 at age 12 for acute myelogenous leukemia. It also marked the first time Hall would lace up her running shoes for the Boston Marathon. “When I heard about the marathon in October 2010, I instantly knew that this was how I would celebrate,” she says.
By Jane Roper When our five-year-old daughter was diagnosed with leukemia (ALL) last summer, our world was turned upside down. Extended hospital stays, twice weekly clinic visits, the side effects of chemo and the constant possibility of unexpected hospital admissions mean stress and exhaustion for all of us. And looming in the background of it all is the unspoken worry: will our daughter get through this?
With Brigham and Women’s Hospital and Boston Children’s Hospital, Dana-Farber has performed thousands of stem cell/bone marrow transplants for adult and pediatric patients with blood cancers and other serious illnesses. What’s the difference between these two terms? As it turns out, the only real distinction is in the method of collecting the stem cells. Let’s start with the basics.
Cancer scientists use a wide variety of techniques to study the growth and development of tumor cells. Laboratory research often focuses on individual cells or tissue samples, but to learn how cancers grow and respond to therapies in living organisms, scientists rely on other experimental models. In recent years, zebrafish have become the model of choice for studying many cancer types. Dana-Farber’s A. Thomas Look, MD, who uses zebrafish in his own work, explains why.